Search PubMed⌕ Search

Biomedical subjects

J Murin

Publications and source records attributed to J Murin.

16 recordsLinked to original sources

Cardiovascular effects of aldosterone.

Aldosterone plays an important role in the pathophysiology of sodium/potassium and water homeostasis of the body. It is nowadays clear that aldosterone contributes also to the development of cardio-vascular diseases, such as hypertension, left ventricular hypertrophy, heart failare, renal failare and others, by direct effets on vesels and the heart. The global view on pathophysiology, on harmful effects of aldosterone and on aldosterone in hypertension and heart failare is presented.

Aldosterone↗

The characteristics of deceased and surviving patients with congestive heart failure at a department of internal medicine.

OBJECTIVES: We examined differences between surviving and deceased patients with congestive heart failure (HF). BACKGROUND: Congestive HF is a frequent disease with still increasing incidence, prevalence and poor prognosis. Patients have high mortality. PATIENTS AND METHODS: Over the period of 4 years we followed up 2 groups of matched patients with congestive HF: surviving (27 patients, 77.4+/-7.7 years) and deceased (27 patients, 76.7+/-9.3 years). We examined differences in the incidence and the intensity of risk factors, New York Heart Association class, signs of HF, incidence of complications, differences in echocardiographic parameters, the incidence of left ventricular hypertrophy, and differences in laboratory values (pulmonary, hepatic, renal). Obtained values were tested using statistical methods. RESULTS: We found higher incidence of myocardial infarction in deceased patients (p=0.0148). Surviving patients had lower heart rate (p=0.0115), higher left ventricular ejection fraction (p=0.0307), thicker interventricular septum (p=0.0239), higher values of arterial O2 pressure (p=0.0033), and lower values of proteinuria (p=0.0058). CONCLUSIONS: Patients with poorer prognosis of congestive HF differed from the "healthier" ones by some clinical, echocardiographic, and laboratory parameters, and higher incidence of myocardial infarction. Significant differences of the next examined parameters between observed groups may be obtained by increasing the number of studied patients. (Tab. 5, Ref: 24.)

Aged↗

Anaemia in heart failure.

Despite modern treatment of chronic congestive heart failure, anaemia is associated with significant morbidity and mortality. Anaemia commonly occurs in patients with heart failure. There is positive correlation between the severity of heart failure and the prevalence and severity of anaemia. Anaemia can play an important role in the natural course of chronic heart failure. Normalisation of haematological parameters in chronic heart failure patients may lead not only to symptomatic improvement but may provide therapeutic benefits. (Tab. 2, Ref: 39.)

Anemia↗

The occurrence of malignant carcinoid syndrome in patients with carcinoid tumors.

BACKGROUND: The carcinoid syndrome occurs in about 10% of patients with carcinoid tumors. OBJECTIVES: The main objective of the present study was to determine the presence of the carcinoid syndrome in a group of patients with carcinoid tumor. SUBJECTS AND METHODS: 35 pts with carcinoid tumors (group A--24 pts with metastatic disease, group B--11 pts after resection of the primary tumor with no metastases detected at the time of the investigation) were included into the study. The localisation and the diameter of the primary tumor were ascertained. Somatostatin receptor scintigraphy--Octreoscan and echocardiography were done. The urinary excretion of 5-HIAA was performed. We estimated the presence of the carcinoid syndrome in all patients. RESULTS: We confirmed the difference in the diameter of the primary carcinoid tumor in patients with metastases--group A 3.0 (2.5-4.2) cm by comparison with group B 0.7 (0.6-0.8) cm, (p < 0.001). Patients in the metastatic group are older 64 year (42-70) than pts without metastases--33 y (20-54) (p < 0.01). The amount of the 5-hydroxyindolacetate acid in urine in pts with metastatic carcinoid was statistically significantly higher than in the pts without metastases (p < 0.001). The carcinoid syndrome in the metastatic group was found in 6 patients (25%), with maximum (12.5%) localised in midgut. Out of the whole sample it counts up to 15.1%. During the follow up period, 8 patients from group A died. CONCLUSION: The large diameter of the primary carcinoid tumor and the higher age are the bad prognostic factors in patients with carcinoid tumors. (Tab. 4, Ref. 27.)

Adult↗

Is left ventricular hypertrophy a risk factor in hypertensive patients?

BACKGROUND: Left ventricular hypertrophy (LVH) is supposed to be a risk factor of cardiovascular (CV) complications in hypertensive patients. AIM: To compare clinical events in hypertensives with and without LVH. PATIENTS AND METHODS: 319 hypertensives with LVH (mean age 64.1+/-10.6 ys) and 177 hypertensives without LVH (mean age 62.5+/-11.3 ys). LVH defined by echo Penn convention as left ventricular mass index >134 g/m2 in men and >110 g/m2 in women. Clinical events--heart failure (EF<40 %), left ventricular diastolic dysfunction (echo-doppler: transmitral-flow where peak A>peak E), myocardial infarction (history, ECG, cardiac enzymes), chronic atrial fibrillation (more than 2 weeks duration), mitral regurgitation (echo) and renal involvement (creatininemia>120 micromol/l). The two groups of hypertensives were matched by demographic criteria, duration and intensity of hypertension, obesity, diabetes mellitus, lipid serum levels and smoking habits. RESULTS: There were statistically significant at least p<0.05 more CV events (heart failure, left ventricular diastolic dysfunction, myocardial infarction, chronic atrial fibrillation, and mitral regurgitation cases) and renal involvement in LVH-positive patients than in LVH-negative patients. CONCLUSION: LVH is a strong risk factor for clinical events in hypertensives, which necessitates their more intensive treatment, mainly with drugs producing also LVH regression. (Tab. 5, Ref. 48.)

Female↗

The incidence and the characteristics of heart failure patients at a large medical department.

INTRODUCTION: Chronic heart failure (HF) has a prevalence of 6-10 % in patients above the age of 65 years, leading to high mortality, morbidity and re-hospitalization. AIM: To analyse the incidence and the characteristics of patients with HF in a medical department. PATIENTS AND METHODS: 941 patients (males 424, females 517 with an average age of 64 years and 67 years respectively), hospitalized from 1.9.1998 to 28.2.1999 at the 1st Internal Department of the University Hospital. A retrospective analysis of their files: age, diagnosis, duration of hospitalization, and in those patients with HF: the occurrence of risk factors and clinical events( stroke, myocardial infarction, and atrial fibrillation). RESULTS: We have analyzed the incidence of diseases at a medical department where 58.7 % of patients suffered from cardiovascular diseases. Patients with HF represented 13.9 % of all hospitalized patients. Among the risk factors dominated hypertension, diabetes, obesity, hyperlipidemia and smoking. The average duration of hospitalization was 12.66 days in men and 13.67 days in women. The hospitalization period was 15.6 days in hypertensive diabetic males whereas in females it was 15.3 days. These patients were hospitalized in their 5th decade with the incidence of HF increasing with age. Their mortality was 11.5 % while the overall mortality was 9.7 % among all patients hospitalized. Those patients who died suffered from poly-morbidity. CONCLUSION: The prevalence of HF in our patients was 13.9 %. This value is higher than the data from literature. These patients suffered from poly-morbidity (hypertension: 53-75 %, diabetes: 30 %, obesity: 33-38 %, hyperlipidemia: 20-50 %, smoking: 11-32 %, myocardial infarction: 41-50 %) and had a high mortality. (Tab. 5, Fig. 2, Ref. 7.).

Adolescent↗

Beta-blockers in heart failure.

The problem of heart failure (HF) has become a topic of great interest. Until recently, the use of beta-blockers in patients with HF was considered as one of the contraindications which were taught to medical students as realities with a strict policy to avoid them in HF patients. Times have changed and the contraindicated drug is now an advised and preferred one to be used in HF patients with certain advised recommendations for its use in a safe and beneficial way. Even though the use of beta-blockers in HF patients is an important and necessary step towards an optimal treatment of these patients as most of the big studies have proved, still we need to emphasize these benefits in order to achieve more application of these agents in HF patients. Here we analyse the major studies which used beta-blockers in HF patients. It seems that beta-blockers have to be used in all patients with HF with reduced ejection fraction unless a real contraindication exists as they bring up a great benefit towards decreasing mortality and morbidity.

Adrenergic beta-Antagonists↗

Benefits of beta-blockers in heart failure.

The problem of heart failure (HF) has become a topic of great interest. Until recently, the use of beta-blockers in patients with HF was considered as a contraindication. Times have changed and the contraindicated drug is now an advised and preferred one to be used in HF patients with certain advised recommendations for its use in a safe and beneficial way. Still we need to emphasize the benefits of these agents in order to achieve more application in HF patients. Here we try to stress the proved beneficial effects of beta-blockers by major studies in HF patients, and to supply the reader with practical information regarding the use of these agents with a look at the frequency of using them and the possible reasons behind their underuse. The files of heart failure patients admitted to 1st Internal Department in the University Hospital in Bratislava in the period between January and December 1997 were checked to show the magnitude of using beta-blockers in them. Among 150 patients admitted during the above mentioned period only 30 patients (20%) received beta-blockers. It seems that beta-blockers have to be used in all patients with HF with reduced ejection fraction unless a real contraindication exists, but the actual data shows that beta-blockers are still underused. (Tab. 2, Ref. 30.)

Adrenergic beta-Antagonists↗

Relation of left ventricular hypertrophy to cardiovascular complications in diabetic hypertensives.

The presence of diabetes mellitus and other risk factors of atherosclerosis, such as obesity, smoking and hyperlipidemia, in hypertensive patients makes the prognosis worse. Authors compared the clinical findings in diabetic hypertensive patients with and without left ventricular hypertrophy, the presence of which was diagnosed and defined by echocardiography. The study is based on the analysis of hospital records of 115 hypertensive patients treated at our department during the period 1998-1999. Left ventricular hypertrophy (LVH) was defined by echocardiography as left ventricular mass index > 134 g/m2 in men and > 110 g/m2 in women. Left ventricular hypertrophy was found in 79 patients (mean age 64.6 ys) but not in 36 patients (mean age 63.3 ys). Both groups were matched as to age and sex, intensity and duration of hypertension and diabetes, obesity, smoking and hyperlipidemia. In LVH-positive patients, there was a statistically significant incidence of heart failure, mitral regurgitation and renal involvement and a more non-significant incidence of left ventricular diastolic dysfunction, myocardial infarction, chronic atrial fibrillation and stroke than in LVH-negative ones. Left ventricular hypertrophy usually complicates the course of hypertension. Authors recommend to investigate the presence of left ventricular hypertrophy in hypertensives as it carries a much more complicated course of the disease. (Tab. 5, Ref. 28.)

Arteriosclerosis↗

[Primary pulmonary hypertension].

Authors described a case of 26-year old patient with history of progressing dyspnea and repetitive syncopes. In history is intermittent hemoptysis and dyspnea from 1990. Diagnosis of thromboembolic disease was suspected. Clinical picture was dominated by dyspnea, central cyanosis, sinus tachycardia without pulmonary signs of hearth failure. On ecg there is right heart hypertrophy. Echocardiographic examination shows dilatation of right heart, systolic pressure in a. pulmonalis about 90 mmHg and tricuspidal regurgitation of the III. degree. Phlebothrombosis was not found. Complete hemocoagulation examination excluded a primary procoagulating hematologic disease. Pulmonary angiography did not confirm thromboembolic disease but found a high grade pulmonary hypertension--mean pulmonary arterial pressure of 93 mmHg. After complex pneumological examination, including HRCT, and other examinations the diagnosis of primary pulmonary hypertension was made. Patient is indicated to lung transplantation. (Fig. 4, Ref. 9.)

Adult↗

[Left ventricular hypertrophy in hypertension].

Left ventricular hypertrophy LVH is supposed to be a useful marker of cardiovascular complications during the course of hypertension. Occurrence of other risk factors of atherosclerosis in these hypertensive patients such as hyperlipidemia and smoking deteriorate the prognosis too. The authors compared clinical findings in hypertensive patients with and without left ventricular hypertrophy defined by echocardiography. Hospital records of 185 hypertensive patients treated at our medical department during years 1996-1999 were analysed. Left ventricular hypertrophy was defined by echocardiography (Penn convention) as left ventricular mass index > 134 g/m2 in men and > 110 g/m2 in women. Presence of LVH was found in 109 patients (mean age 66.7 years), absence of LVH in 76 patients (mean age 64.7 years). Both groups of hypertensive patients were matched by demographic parameters by the presence of hyperlipidemia and by smoking habits. Hypertensive patients with diabetes mellitus and obesity were excluded. They were statistically significant in the incidence of heart failure, myocardial infarction, renal failure and mitral regurgitation, and non-significant in the incidence of left ventricular diastolic dysfunction. There were more cardiovascular complications in LVH-positive patients than in those with LVH-negative findings. The incidence of stroke was slightly higher in LVH-negative patients. Left ventricular hypertrophy in patients with hypertension brings usually a complicated course of the disease. The authors recommend to examine the patients with arterial hypertension for the presence of left ventricular hypertrophy as it complicates the course of the disease significantly. (Tab. 3, Fig. 2, Ref. 26.)

Adult↗

[In Process Citation]

The therapy of AMI is aimed at the prevention of death, minimalization of discomfort caused by the disease and the reduction of the infarction focus (as soon and as markedly as possible) since the success of this step links with the later short-term as well as the long-term prognoses of the patient. (Tab. 2, Ref. 15.)

Journal Article↗

Remodeling in myocardial infarction and body surface potential maps.

This study deals with the capabilities of body surface integral and departure maps to evaluate the chronic stage of myocardial infarction based on dividing the left ventricle into 12 segments. The effects of ventricular remodeling on electrocardiographic potential distributions are considered. A 61-year-old male patient was examined five times by body surface potential mapping during a period of 9 months after acute myocardial infarction. Integral maps were calculated for 60 ms after QRS onset and compared with mean data from a control group using departure maps. Integral maps showed a continual reduction of negative potentials in the lower half of the torso with time. The negative area covered the lower torso in the departure maps during the whole study, but its form and value changed. According to the location of the departure area, the surface projection of the scar moved from a position corresponding to inferior segments to a position corresponding to posterior segments. Its size also decreased. Echocardiographic examinations showed progressive enlargement of both ventricles with time. Therefore, the authors postulate that the changing pattern of body surface potential maps was mainly influenced by ventricular remodeling after myocardial infarction.

Electrocardiography↗

Gliding window fast Fourier transform analysis--a new method for discovering the contribution of higher frequencies in signal-averaged ECG.

OBJECTIVE: An attempt to detect the 'parasitic contribution' of high frequencies in the electrocardiogram signal. DESIGN: A new method--gliding window fast Fourier transform analysis (GWFFTA)--was developed. It was applied in healthy subjects and in patients with acute myocardial infarction. SETTING: Faculty of Medicine and University Hospital. PATIENTS: The GWFFTA was used in 29 healthy volunteers and in a group of 30 patients with myocardial infarction, on day 7 to 14 after admission to a coronary unit. INTERVENTION: Noninvasive examination, performed under standard conditions. MAIN RESULTS: GWFFTA provides better reproducible results compared with 'classic' fast Fourier transform analysis. The parasitic contribution of high frequencies within QRS complex and ST segment in patients with acute myocardial infarction is independent of presence or absence of late potentials. Contribution of high frequencies are three times higher in patients with acute myocardial infarction than in healthy probands. CONCLUSIONS: GWFFTA is a reproducible method of detection of high frequencies during whole heart activation. Contribution of high frequencies in patients with acute myocardial infarction reflects the state of the entire myocardium. It is also confirmed by the lack of correlation with the presence or absence of late potentials. Late potentials are more reflective of focal changes.

Action Potentials↗

Does the heart electric activation split upon the infarcted area? An attempt at its detection by high-resolution electrocardiography.

Based on the presumption of the activation front splitting, the authors present their own proposal for the estimation of the myocardial electric activation course and for the detection of micropotentials 'hidden' within QRS complexes by the method of high-resolution electrocardiography. After filtration of QRS complex the values of delta RMS and those of cumulative amplitudes are calculated from the initial and from the terminal parts of QRS complexes. The presence of late potentials is reflected in a slowing down of the termination of activation course. As compared with healthy subjects, a slower rise of activation was observed in patients with myocardial infarction of the anterior wall. The curves of cumulative amplitudes rose very slowly during the first 70 ms of heart ventricle activation, explained according to the hypothesis of authors as being due to splitting of the activation front at the infarction focus. The usefulness of the proposed method was checked in patients with arterial hypertension and left ventricular hypertrophy, and in a group of patients with myocardial infarction. By the construction of cumulative amplitude curves from the onset of filtered QRS complexes, myocardial foci not reflected by 'classic' late potentials can be detected. The partial cumulative amplitudes of the QRS complex are suitable for comparative studies.

Adolescent↗